Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733] (S1476558617302270) (10.1016/j.neo.2017.07.001))

Swetha Tati, John C. Fisk, Julia Abdullah, Loukia Karacosta, Taylor Chrisikos, Padraic Philbin, Susan Morey, Diala Ghazal, Fatma Zalzala, Joseph Jessee, Sally Quataert, Stephen Koury, David Moreno, Jing Ying Eng, Vladislav V. Glinsky, Olga V. Glinskii, Muctarr Sesay, Anthony W. Gebhard, Karamverr Birthare, James R. OlsonKate Rittenhouse-Olson

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

The authors regret that the author name “Fatma Zazala” was misspelled. The name should have been “Fatma Zalzala.” The authors would like to apologize for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)118
Number of pages1
JournalNeoplasia (United States)
Volume20
Issue number1
DOIs
StatePublished - Jan 2018
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733] (S1476558617302270) (10.1016/j.neo.2017.07.001))'. Together they form a unique fingerprint.

Cite this